Michael Catelani

Michael Catelani

Directeur Financier/CFO chez ANIXA BIOSCIENCES, INC.

Fortune : 86 304 $ au 30/04/2024

57 ans
Health Technology
Commercial Services
Consumer Services

Provenance du réseau au premier degré de Michael Catelani

EntitéType d'entitéIndustrie
Public Company Biotechnology 13
6
Subsidiary Biotechnology 6
3
Subsidiary Pharmaceuticals: Major 3
1
Extinct Medical Specialties 1

Graphique Sociétés connectées au second degré

Relation dans plusieurs entreprises

Sociétés connectées à Michael Catelani via son réseau personnel

SociétéSecteurPersonnes liéesPoste principal
Hotels/Resorts/Cruise lines

Emily Gottschalk

Sales & Marketing

Specialty Stores

Emily Gottschalk

Sales & Marketing

Pharmaceuticals: Major

John W. Rawling

Director of Finance/CFO

CRYOSITE LIMITED Miscellaneous Commercial Services

Peter Francis

Director/Board Member

NSX LIMITED Investment Banks/Brokers

Raymond Laurence Whitten

Chairman

KGL RESOURCES LIMITED Other Metals/Minerals

John W. Rawling

Director of Finance/CFO

University of Pittsburgh College/University

David Suhy

Pamela Garzone

Undergraduate Degree

Doctorate Degree

JAPAN TOBACCO, INC. Tobacco

Yasuo Urata

Corporate Officer/Principal

ONO PHARMACEUTICAL CO., LTD. Pharmaceuticals: Major

Yasuo Urata

Corporate Officer/Principal

OPTISCAN IMAGING LIMITED Medical Specialties

Peter Francis

Director/Board Member

Hotels/Resorts/Cruise lines

Emily Gottschalk

Sales & Marketing

John Marshall Law School (Georgia) College/University

Bruce F. Johnson

Graduate Degree

Insurance Brokers/Services

John W. Rawling

Director of Finance/CFO

RISION LIMITED Packaged Software

Peter Francis

Director/Board Member

College/University

Peter Francis

Graduate Degree

AEOLUS PHARMACEUTICALS, INC. Pharmaceuticals: Major

David Cavalier

Amit Kumar

Chairman

Director/Board Member

Bradley University College/University

Bruce F. Johnson

Undergraduate Degree

WONIK CUBE CORP. Wholesale Distributors

Yasuo Urata

Director/Board Member

The University of Sydney College/University

Raymond Laurence Whitten

Graduate Degree

Miscellaneous Commercial Services

Amit Kumar

Arnold Baskies

Director/Board Member

Chairman

Movies/Entertainment

Emily Gottschalk

Chief Executive Officer

University of Technology Sydney College/University

Raymond Laurence Whitten

Graduate Degree

Investment Managers

John W. Rawling

Director of Finance/CFO

Miscellaneous Commercial Services

John W. Rawling

Director of Finance/CFO

Packers Trading Co., Inc.

Bruce F. Johnson

President

Pharmaceuticals: Other

John W. Rawling

Director of Finance/CFO

VIKING MINES LIMITED Precious Metals

Raymond Laurence Whitten

Chairman

ONCOLYS BIOPHARMA INC. Biotechnology

Yasuo Urata

Founder

Medical Specialties

Peter Francis

Director/Board Member

Movies/Entertainment

John W. Rawling

Director of Finance/CFO

Miscellaneous Commercial Services

Peter Francis

Director/Board Member

Workcover Authority of New South Wales

Raymond Laurence Whitten

Corporate Officer/Principal

BIOXYNE LIMITED Miscellaneous Commercial Services

Peter Francis

Director/Board Member

FAL Lawyers

Peter Francis

Corporate Officer/Principal

Miscellaneous Commercial Services

Raymond Laurence Whitten

Chairman

Miscellaneous Commercial Services

Bruce F. Johnson

Director/Board Member

Cornell University School of Hotel Administration College/University

Emily Gottschalk

Undergraduate Degree

Rowan University School of Osteopathic Medicine College/University

Arnold Baskies

Corporate Officer/Principal

BCAL DIAGNOSTICS LIMITED Medical/Nursing Services

Peter Francis

Director/Board Member

INOVIQ LTD Medical/Nursing Services

Peter Francis

Chief Tech/Sci/R&D Officer

Neuroscope Ltd.

Peter Francis

Director/Board Member

City of Sydney Law Society

Raymond Laurence Whitten

President

Investment Managers

Arnold Baskies

Consultant / Advisor

Ideation USA LLC

Emily Gottschalk

Founder

BENITEC BIOPHARMA INC. Biotechnology

Peter Francis

Director/Board Member

Medical Specialties

Peter Francis

Director/Board Member

NANOMIX CORPORATION Pharmaceuticals: Other

Thomas Schlumpberger

Chief Executive Officer

Statistiques

Internationale

Australie 27
Etats-Unis 18
Japon 5
Canada 2
Corée du Sud 2

Sectorielle

Consumer Services 13
Health Technology 11
Commercial Services 8
Finance 5
Non-Energy Minerals 3

Opérationnelle

Director/Board Member 82
Corporate Officer/Principal 39
Chairman 33
Independent Dir/Board Member 25
Chief Executive Officer 19
  1. Bourse
  2. Insiders
  3. Michael Catelani
  4. Connexions Sociétés